Chugai and Biofourmis Collaborate to Develop Solutions for Digitally Measuring Endometriosis Pain

 Chugai and Biofourmis Collaborate to Develop Solutions for Digitally Measuring Endometriosis Pain

Shots:

  • The collaboration will deploy Biofourmis’ Biovitals platform to co-develop a novel digital technology for the objective assessment of pain using biosensors and AI-based algorithms. The solutions will be validated in the global study that enrolls 120+ endometriosis patients
  • The digital solution for managing patients with endometriosis in an ambulatory setting will include a wearable, clinical-grade biosensor to capture physiology biomarkers and a mobile app to monitor symptoms, with a gamification engine for patient engagement
  • The technology applies analytics to physiology biomarkers for quantification of pain and will include a clinician-facing web dashboard for remote review and intervention.  Chugai is demonstrating its commitment to applying the advanced digital technologies for better understanding the real-life needs of patients and to develop innovative solutions for society, as outlined in the CHUGAI DIGITAL VISION 2030

Click here to read full press release/ article | Ref: PRNewswire | Image: Biofourmis

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post